21 May 2013
Keywords: update, fda, review, sanofi, rimonabant, french, drug
Article | 02 April 2007
French drug major Sanofi-Aventis says that the US Food and Drug Administration notice for its first-in-class selective cannabinoid-1
receptor antagonist ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 April 2007
20 May 2013
© 2013 thepharmaletter.com